InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-12.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by ROBIN SHERRINGTON, Directeur Exécutif. Director active across 2 companies, notably Xenon Pharmaceuticals Inc.. In total, 6 disclosures have been published. Activity tracked since 28 May 2021. The latest transaction was disclosed on 7 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
1,234 shares@ US$9.8519.3% of flowCommon SharesSEC:0000950170-24-028795:0
8,398 shares0Common SharesSEC:0000950170-24-000304:0
17,488 shares@ US$2.6780.7% of flowCommon SharesSEC:0001209191-22-048508:0
1,234 shares@ US$3.670.0001% mcap5.1% of flowCommon SharesSEC:0001209191-22-017318:0
12,345 shares@ US$3.7647.4% of flowCommon SharesSEC:0001209191-21-036802
12,345 shares@ US$3.760.0007% mcap47.4% of flowCommon SharesSEC:0001209191-21-036802:0
6 of 6 declarations
About ROBIN SHERRINGTON
Robin Sherrington is Executive Vice President of Strategy and Innovation at Xenon Pharmaceuticals Inc. She is responsible for strategic leadership and innovation within the company, contributing to its development.
